United Therapeutics | UTHR - Net Income


United Therapeutics reported $364.3M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Amarin USD -1.22M 6.51M Dec/2025
Ardelyx USD -407K 562K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
BioCryst Pharmaceuticals USD 245.84M 232.95M Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Insmed USD -328.48M 41.54M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
J&J USD 5.12B 36M Dec/2025
Lexicon Pharmaceuticals USD -15.53M 2.76M Dec/2025
Moderna USD -200M 625M Sep/2025
Omeros USD -32.23M 23.81M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
United Therapeutics USD 364.3M 25.6M Dec/2025
Vertex Pharmaceuticals USD 1.19B 108.2M Dec/2025